drugset

drugset / Trial / NCT02244762

Pharmacokinetics and Metabolism of Hydrocodone Bitartrate Extended-Release (HC-ER) in Subjects With Renal Impairment

NCT02244762 ↗

Phase 1 Completed 37 enrolled Zogenix, Inc.

Non-randomizedParallel-groupOpen-labelOther

Summary

Determine the influence of renal impairment on the pharmacokinetics and metabolism of Hydrocodone Bitartrate Extended-Release (HC-ER) 20 mg capsules

Timeline

Start: 2011-02
Primary completion: 2011-05
Completion: 2011-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Hydrocodone	Unknown	20 mg	—

Indications